查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1312313

电子处方市场：按组件（服务、解决方案）、部署（云端、本地）、最终用户 - 2023-2030 年全球预测

ePrescribing Market by Component (Services, Solution), Deployment (On-Cloud, On-Premises), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2023 年，全球电子处方市场规模将达到 25.0915 亿美元，年复合成长率为 22.90%，预计到 2030 年将以惊人的速度增长至 106.4285 亿美元。

FPNV定位矩阵

FPNV 定位矩阵对于评估全球电子处方市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.电子处方的全球市场规模和预测是多少？

2. 在预测期内，COVID-19 对全球电子处方市场的阻碍因素和影响有哪些？

3.全球电子处方市场在预测期内需要投资哪些产品/细分市场/用途/领域？

4.ePrescribing在全球市场的竞争策略是什么？

5.全球电子处方市场的技术趋势和法律规范是什么？

6.全球电子处方市场主要供应商的市占率为何？

7.您认为ePrescribing适合进入全球市场的型态和策略倡议为何？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 提高病人安全并减少处方错误
      • 提高患者便利性和依从性
      • 预防药物滥用和改善药物监测
    • 抑制因素
      • 实施成本和投资报酬率
      • 技术复杂性和资料可用性
    • 机会
      • 整合电子处方软体
      • HIPAA 合规性执行
    • 任务
      • 不愿意介绍
      • 病患资讯安全问题
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化
    • 科技趋势

第6章电子处方市场：依组成部分

  • 介绍
  • 服务
    • 维护与支援服务
    • 网路和部署服务
    • 培训和教育服务
  • 解决方案
    • 一体化解决方案
    • 独立解决方案

第7章电子处方市场：依部署

  • 介绍
  • 在云端
  • 本地

第8章电子处方市场：依最终使用者划分

  • 介绍
  • 医院
  • 长期照护提供者
    • 辅助生活设施
    • 家庭医疗设施
    • 安宁疗护
    • 疗养院
  • 药局
  • 医生

第9章美洲电子处方市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区电子处方市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲电子处方市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-433BAD49EE2F

The Global ePrescribing Market is forecasted to grow significantly, with a projected USD 2,509.15 million in 2023 at a CAGR of 22.90% and expected to reach a staggering USD 10,642.85 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global ePrescribing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global ePrescribing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Component, market is studied across Services and Solution. The Services is further studied across Maintenance & Support Services, Network & Implementation Services, and Training & Education Services. The Solution is further studied across Integrated Solutions and Standalone Solutions. The Services is projected to witness significant market share during forecast period.

Based on Deployment, market is studied across On-Cloud and On-Premises. The On-Premises is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Hospitals, Long Term Care Providers, Pharmacies, and Physicians. The Long Term Care Providers is further studied across Assisted Living Facilities, Home Healthcare Facilities, Hospice, and Nursing Facilities. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global ePrescribing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global ePrescribing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global ePrescribing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global ePrescribing Market?

4. What is the competitive strategic window for opportunities in the Global ePrescribing Market?

5. What are the technology trends and regulatory frameworks in the Global ePrescribing Market?

6. What is the market share of the leading vendors in the Global ePrescribing Market?

7. What modes and strategic moves are considered suitable for entering the Global ePrescribing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. ePrescribing Market, by Component, 2022 vs 2030
  • 4.3. ePrescribing Market, by Deployment, 2022 vs 2030
  • 4.4. ePrescribing Market, by End-User, 2022 vs 2030
  • 4.5. ePrescribing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Improving patient safety and reduce prescription errors
      • 5.1.1.2. Increasing patient convenience and medication compliance
      • 5.1.1.3. Drug abuse prevention and improved drug surveillance
    • 5.1.2. Restraints
      • 5.1.2.1. Implementation cost and ROI
      • 5.1.2.2. Technical complexity and data availability
    • 5.1.3. Opportunities
      • 5.1.3.1. Integrated e-prescription software
      • 5.1.3.2. Enforcement by HIPAA compliance
    • 5.1.4. Challenges
      • 5.1.4.1. Reluctance towards the adoption of technology
      • 5.1.4.2. Patient information security issues
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization
    • 5.9.1. Technology Trend

6. ePrescribing Market, by Component

  • 6.1. Introduction
  • 6.2. Services
    • 6.2.1. Maintenance & Support Services
    • 6.2.2. Network & Implementation Services
    • 6.2.3. Training & Education Services
  • 6.3. Solution
    • 6.3.1. Integrated Solutions
    • 6.3.2. Standalone Solutions

7. ePrescribing Market, by Deployment

  • 7.1. Introduction
  • 7.2. On-Cloud
  • 7.3. On-Premises

8. ePrescribing Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Long Term Care Providers
    • 8.3.1. Assisted Living Facilities
    • 8.3.2. Home Healthcare Facilities
    • 8.3.3. Hospice
    • 8.3.4. Nursing Facilities
  • 8.4. Pharmacies
  • 8.5. Physicians

9. Americas ePrescribing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific ePrescribing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa ePrescribing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. EPRESCRIBING MARKET RESEARCH PROCESS
  • FIGURE 2. EPRESCRIBING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. EPRESCRIBING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. EPRESCRIBING MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
  • FIGURE 5. EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2022 VS 2030 (%)
  • FIGURE 6. EPRESCRIBING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. EPRESCRIBING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. EPRESCRIBING MARKET DYNAMICS
  • FIGURE 9. EPRESCRIBING MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. EPRESCRIBING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. EPRESCRIBING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. EPRESCRIBING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. EPRESCRIBING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. EPRESCRIBING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 5. EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 6. EPRESCRIBING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. EPRESCRIBING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. EPRESCRIBING MARKET SIZE, BY NETWORK & IMPLEMENTATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. EPRESCRIBING MARKET SIZE, BY TRAINING & EDUCATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 11. EPRESCRIBING MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. EPRESCRIBING MARKET SIZE, BY INTEGRATED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. EPRESCRIBING MARKET SIZE, BY STANDALONE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 15. EPRESCRIBING MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. EPRESCRIBING MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. EPRESCRIBING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 20. EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. EPRESCRIBING MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. EPRESCRIBING MARKET SIZE, BY HOME HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. EPRESCRIBING MARKET SIZE, BY HOSPICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. EPRESCRIBING MARKET SIZE, BY NURSING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. EPRESCRIBING MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. EPRESCRIBING MARKET SIZE, BY PHYSICIANS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
  • TABLE 277. EPRESCRIBING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 278. EPRESCRIBING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 279. EPRESCRIBING MARKET LICENSE & PRICING